Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
14.07. | Exicure files to sell 5.16M shares of common stock by selling shareholders | 1 | Seeking Alpha | ||
14.07. | EXICURE, INC. - S-1, General form for registration of securities | 1 | SEC Filings | ||
02.07. | XFRA DIVERSE ISINS: WIEDERAUFNAHME/RESUMPTION | 403 | Xetra Newsboard | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
30.06. | Progress Software, Exicure And 3 Stocks To Watch Heading Into Monday | 8 | Benzinga.com | ||
27.06. | EXICURE, INC. - 10-Q, Quarterly Report | 3 | SEC Filings | ||
27.06. | EXICURE, INC. - 8-K, Current Report | 1 | SEC Filings | ||
EXICURE Aktie jetzt für 0€ handeln | |||||
10.06. | EXICURE, INC. - 8-K, Current Report | 1 | SEC Filings | ||
28.05. | EXICURE, INC. - 8-K, Current Report | 1 | SEC Filings | ||
28.05. | Exicure receives Nasdaq non-compliance notice for late quarterly filing | 1 | Seeking Alpha | ||
28.05. | Exicure faces Nasdaq non-compliance notice | 1 | Investing.com | ||
06.05. | EXICURE, INC. - 8-K, Current Report | 3 | SEC Filings | ||
14.04. | EXICURE, INC. - 8-K, Current Report | 1 | SEC Filings | ||
18.03. | EXICURE, INC. - 10-K, Annual Report | 1 | SEC Filings | ||
18.03. | EXICURE, INC. - 8-K, Current Report | 1 | SEC Filings | ||
13.03. | Pre-market Movers: Y-mAbs Therapeutics, Aveanna Healthcare, UiPath, Exicure, CareCloud | 649 | AFX News | SANTA CLARA (dpa-AFX) - The following are some of the stocks making big moves in Thursday's pre-market trading (as of 08.55 A.M. ET).In the Green Aveanna Healthcare Holdings Inc. (AVAH) is up... ► Artikel lesen | |
05.03. | EXICURE, INC. - 8-K, Current Report | - | SEC Filings | ||
21.02. | EXICURE, INC. - 8-K, Current Report | - | SEC Filings | ||
23.01. | Exicure, back from brink and under new management, buys GPCR's US unit and clinical-stage drug | 2 | FierceBiotech | ||
23.01. | Exicure Buys GPCR USA From GPCR Therapeutics, Signs L&C Deal; Stock Climbs | 1 | RTTNews | ||
27.12.24 | Exicure, Inc. Partners with GPCR Therapeutics to Fuel New Growth in Biotech | 218 | Business Wire | CHICAGO--(BUSINESS WIRE)--Exicure, Inc. (Nasdaq: XCUR, "Exicure", "the Company"), has announced the signing of a Memorandum of Understanding (MOU) with GPCR Therapeutics, Inc. ("GPCR Therapeutics")... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
NOVARTIS | 99,48 | +1,38 % | Novartis setzt Wachstumstempo weiter fort | Basel - Novartis ist auch im zweiten Quartal 2025 wieder stark gewachsen. Damit knüpft der Pharmakonzern an das Wachstumstempo der vorangegangenen Quartale an. Den Ausblick für das Gesamtjahr heben... ► Artikel lesen | |
GILEAD SCIENCES | 93,71 | +1,14 % | Hookipa, having sold off vaccines to Gilead, opts to wind down | ||
AURORA CANNABIS | 4,270 | +6,35 % | BRISANTE Meldung setzt Aurora Cannabis Aktionäre unter Zugzwang. Bitte reagieren Sie jetzt sofort! | ||
CANOPY GROWTH | 1,066 | +10,70 % | Canopy Growth: Buy, Sell, or Hold in July 2025? | ||
MERCK & CO | 69,60 | +2,50 % | Veeva Systems: Merck Commits to Veeva Vault CRM | Deep application provides foundation for commercial execution
PLEASANTON, Calif., July 21, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Merck (NYSE: MRK), known... ► Artikel lesen | |
ELI LILLY | 660,60 | +0,87 % | Eli Lilly: Warten auf Impulse | In den letzten Wochen zeigte die Aktie eines der bedeutendsten Pharmaunternehmen der Welt auffallend wenig Bewegung Den vollständigen Artikel lesen ... ► Artikel lesen | |
ASTRAZENECA | 119,60 | +1,10 % | Buy or Goodbye?: Meta, Hensoldt, Astrazeneca und Thyssenkrupp - Die Analystenstimmen des Tages | © Foto: Britta Pedersen/zb/dpaMeta, Hensoldt, Astrazeneca und Thyssenkrupp: So bewerten Top-Analysten die Aktien. Ein Überblick.Jefferies hebt das Kursziel für Meta an Das Analysehaus Jefferies hat... ► Artikel lesen | |
HALO COLLECTIVE | 0,010 | 0,00 % | Waters Corporation Buys Halo Labs | WASHINGTON (dpa-AFX) - Waters Corporation (WAT), an analytical instruments and software firm, said on Wednesday that it has acquired Halo Labs, a company focused on specialized imaging technologies... ► Artikel lesen | |
TILRAY BRANDS | 0,660 | +14,31 % | Tilray stock pops 15%: should you sell TLRY shares into the strength? | ||
INNOCAN PHARMA | 0,128 | -1,16 % | FDA Hammer! CBD-Studie mit riesigen Auswirkungen! | ||
TAAT GLOBAL ALTERNATIVES | 0,136 | -100,00 % | CSE Bulletin: Suspensions - Blender Bites Limited, TAAT Global Alternatives Inc. | Toronto, Ontario--(Newsfile Corp. - Le 16 mai/May 2025) - Effective immediately, the following companies are suspended pursuant to CSE Policy 3. The suspensions are considered Regulatory Halts as... ► Artikel lesen | |
ARZNEIWERK AG VIDA | 0,300 | -36,97 % | XETR DELETION OF INSTRUMENTS FROM XETRA - 30.06.2025 | The following instruments on XETRA do have their last trading day on 30.06.2025Die folgenden Instrumente auf XETRA haben ihren letzten Handelstag am 30.06.2025ISIN NameDE000A3EX3G0 GORE German Office... ► Artikel lesen | |
CRONOS GROUP | 1,857 | +4,09 % | High Tide schließt mit Cronos Group Inc. eine Vereinbarung über Wandelschuldverschreibungen im Wert von 30 Millionen $ ab | CALGARY, AB, und TORONTO, ON, 16. Juli 2025 / IRW-Press / High Tide Inc. ("High Tide" oder das "Unternehmen") (Nasdaq: HITI) (TSXV: HITI) (FWB: 2LYA), das
erfolgreiche, auf den Einzelhandel fokussierte... ► Artikel lesen | |
EYEPOINT PHARMACEUTICALS | 9,026 | +0,16 % | EyePoint Pharmaceuticals, Inc.: EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) | WATERTOWN, Mass., July 16, 2025 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of patients... ► Artikel lesen | |
IONIS PHARMACEUTICALS | 35,390 | -0,45 % | Ionis: HAE-Medikament Donidalorsen reduziert Anfallsraten in Studie signifikant |